The transparency of published health technology assessment-based recommendations on pharmaceutical reimbursement in Poland

被引:7
作者
Bochenek, Tomasz [1 ]
Kocot, Ewa [2 ]
Rodzinka, Marcin [3 ]
Godman, Brian [4 ,5 ]
Maciejewska, Katarzyna [3 ]
Kamal, Susan [6 ]
Pilc, Andrzej [7 ]
机构
[1] Jagiellonian Univ, Dept Drug Management, Fac Hlth Sci, Coll Med, PL-31531 Krakow, Poland
[2] Jagiellonian Univ, Hlth Econ & Social Secur Dept, Fac Hlth Sci, Coll Med, Krakow, Poland
[3] Jagiellonian Univ, Hlth Promot Dept, Fac Hlth Sci, Coll Med, Krakow, Poland
[4] Karolinska Inst, Div Clin Pharmacol, Stockholm, Sweden
[5] Strathclyde Univ, Strathclyde Inst Pharm & Biomed Sci, Glasgow, Lanark, Scotland
[6] Univ Lausanne, Univ Geneva, Sch Pharmaceut Sci, Community Pharm Dept, Geneva, Switzerland
[7] Polish Acad Sci, Inst Pharmacol, Dept Neurobiol, Krakow, Poland
关键词
Health technology assessment; HTA; pharmaceutical reimbursement; public information; citizens' rights; transparency; Poland; RISK-SHARING ARRANGEMENTS; INVOLVEMENT; MEDICINES;
D O I
10.1080/14737167.2017.1262767
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Background: The appropriate access to public information is very important for healthcare system stakeholders. The goal of this study was to examine how the execution of the formally existing right to public information on the HTA-based recommendations on reimbursement of new health technologies from public funds has been changing in Poland.Methods: All recommendations published within two predefined equal periods of time between 2013 and 2015 were analyzed. The gathered data was subjected to statistical analysis.Results: The frequency and intensity of censoring the published HTA-based recommendations on the pharmaceutical reimbursement has diminished. The text readability and clarity of message has improved, although the degree of decisiveness of the recommendations has dropped.Conclusion: The positive changes in the public communication policy should be continued. The transparency of the HTA-based recommendations should be increased further in some areas in the future.
引用
收藏
页码:385 / 400
页数:16
相关论文
共 50 条
[41]   Health technology assessment for pharmaceutical regulation in the European Union: do we need another body? [J].
Padula, Anna ;
Garattini, Livio .
JOURNAL OF THE ROYAL SOCIETY OF MEDICINE, 2020, 113 (01) :12-15
[42]   Pharmaceutical Market Access and the Challenges of Health Technology Assessment in the United Kingdom [J].
Tolley, Keith .
DRUG DEVELOPMENT RESEARCH, 2010, 71 (08) :478-484
[43]   Applying health technology assessment to pharmaceutical care: pitfalls and future directions [J].
Simoens, S ;
Laekeman, G .
PHARMACY WORLD & SCIENCE, 2005, 27 (02) :73-75
[44]   Applying health technology assessment to pharmaceutical care: pitfalls and future directions [J].
Steven Simoens ;
Gert Laekeman .
Pharmacy World and Science, 2005, 27 :73-75
[45]   Health technology assessment and comparative effectiveness research: a pharmaceutical industry perspective [J].
Hao, Yanni ;
Thomas, Adrian .
EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 2013, 13 (04) :447-454
[46]   Using health technology assessment to put pharmaceutical care on the political agenda [J].
Traulsen, JM ;
Klinke, BO .
PHARMACY WORLD & SCIENCE, 2004, 26 (02) :61-63
[47]   Co-construction of health technology assessment recommendations with patients: An example with cardiac defibrillator replacement [J].
Pomey, Marie-Pascale ;
Brouillard, Philippe ;
Ganache, Isabelle ;
Lambert, Laurie ;
Boothroyd, Lucy ;
Collette, Caroline ;
Bedard, Sylvain ;
Gregoire, Alexandre ;
Pelaez, Sandra ;
Demers-Payette, Olivier ;
Goetghebeur, Mireille ;
de Guise, Michele ;
Roy, Denis .
HEALTH EXPECTATIONS, 2020, 23 (01) :182-192
[48]   R WE ready for reimbursement? A round up of developments in real-world evidence relating to health technology assessment [J].
Simpson, Alex ;
Ramagopalan, Sreeram, V .
JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH, 2021, 10 (10) :797-799
[49]   Impact of CEDIT recommendations:: An example of health technology assessment in a hospital network [J].
Bodeau-Livinec, F ;
Simon, E ;
Montagnier-Petrissans, C ;
Joël, ME ;
Féry-Lemonnier, E .
INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE, 2006, 22 (02) :161-168
[50]   Designing collaborations involving health technology assessment: discussions and recommendations from the 2024 health technology assessment international global policy forum [J].
Trowman, Rebecca ;
Migliore, Antonio ;
Ollendorf, Daniel A. .
INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE, 2024, 40 (01)